初潮过早、未产与提前绝经及早期自然绝经风险
这项汇总分析纳入英国、斯堪的纳维亚、澳大利亚和日本九项观察性研究的51450名绝经后女性,发现初潮≤11岁与未产均与提前绝经(末次月经<40岁)和早期绝经(40-44岁)风险升高相关,两者并存时风险进一步放大。
要点
- 初潮≤11岁者提前绝经风险为初潮12-13岁者的1.80倍(RRR 1.80,95%CI 1.53-2.12)。
- 未产者提前绝经风险为有子女者的2.26倍(RRR 2.26,95%CI 1.84-2.77)。
- 初潮≤11岁且未产者提前绝经风险为初潮≥12岁且≥2孩者的5.64倍(95%CI 4.04-7.87)。
核心结论
- 初潮过早(≤11岁)是提前绝经和早期绝经的危险因素,对未产女性该风险被放大。
研究设计与样本
- 汇总分析纳入英国、斯堪的纳维亚、澳大利亚和日本九项观察性研究的51450名绝经后女性,数据来自InterLACE国际合作项目。
- 采用多因素多项逻辑回归模型估计相对风险比(RRR)及95%CI,并校正研究内相关性。
主要发现
- 末次月经中位年龄为50岁(四分位距48-53岁),2%的女性发生提前绝经,7.6%发生早期绝经。
- 初潮≤11岁(对照12-13岁)与提前绝经(RRR 1.80,95%CI 1.53-2.12)和早期绝经(RRR 1.31,95%CI 1.19-1.44)风险升高相关。
- 未产与提前绝经(RRR 2.26,95%CI 1.84-2.77)和早期绝经(RRR 1.32,95%CI 1.09-1.59)风险升高相关。
- 初潮≤11岁且未产者相比初潮≥12岁且≥2孩者,提前绝经风险为5.64倍(95%CI 4.04-7.87),早期绝经风险为2.16倍(95%CI 1.48-3.15)。
关键数值与推荐
- 初潮年龄分为≤11、12、13、14和≥15岁;产次分为无子女、1个子女和≥2个子女。
- 末次月经年龄分类为提前绝经(<40岁)、早期绝经(40-44岁)、45-49岁、50-51岁、52-53岁和≥54岁。
- 末次月经年龄需经至少12个月闭经确认,且非干预所致(如双侧卵巢切除或子宫切除所致手术绝经)。
临床怎么用
- 作者认为,研究结果支持对初潮过早的女性、尤其是无子女者进行早期监测,以实施预防性健康干预,减轻与早期绝经相关的不良健康结局风险。
局限性
- 多数研究(除出生队列外)依赖回顾性报告的初潮年龄,可能导致一定程度的回忆偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are parity and the timing of menarche associated with premature and early natural menopause? SUMMARY ANSWER: Early menarche (≤11 years) is a risk factor for both premature menopause (final menstrual period, FMP <40 years) and early menopause (FMP 40-44 years), a risk that is amplified for nulliparous women. WHAT IS KNOWN ALREADY: Women with either premature or early menopause face an increased risk of chronic conditions in later life and of early death. Findings from some studies suggest that early menarche and nulliparity are associated with early menopause, however overall the evidence is mixed. Much of the evidence for a direct relationship is hampered by a lack of comparability across studies, failure to adjust for confounding factors and inadequate statistical power. STUDY DESIGN, SIZE, DURATION: This pooled study comprises 51 450 postmenopausal women from nine observational studies in the UK, Scandinavia, Australia and Japan that contribute to the International collaboration for a Life course Approach to reproductive health and Chronic disease Events (InterLACE). PARTICIPANTS/MATERIALS, SETTING, METHODS: Age at menarche (categorized as ≤11, 12, 13, 14 and 15 or more years) and parity (categorized as no children, one child and two or more children) were exposures of interest. Age at FMP was confirmed by at least 12 months of cessation of menses where this was not the result of an intervention (such as surgical menopause due to bilateral oophorectomy or hysterectomy) and categorized as premature menopause (FMP before age 40), early menopause (FMP 40-44 years), 45-49 years, 50-51 years, 52-53 years and 54 or more years. We used multivariate multinomial logistic regression models to estimate relative risk ratio (RRR) and 95% CI for associations between menarche, parity and age at FMP adjusting for within-study correlation. MAIN RESULTS AND THE ROLE OF CHANCE: The median age at FMP was 50 years (interquartile range 48-53 years), with 2% of the women experiencing premature menopause and 7.6% early menopause. Women with early menarche (≤11 years, compared with 12-13 years) were at higher risk of premature menopause (RRR 1.80, 95% CI 1.53-2.12) and early menopause (1.31, 1.19-1.44). Nulliparity was associated with increased risk of premature menopause (2.26, 1.84-2.77) and early menopause (1.32, 1.09-1.59). Women having early menarche and nulliparity were at over 5-fold increased risk of premature menopause (5.64, 4.04-7.87) and 2-fold increased risk of early menopause (2.16, 1.48-3.15) compared with women who had menarche at ≥12 years and two or more children. LIMITATIONS, REASONS FOR CAUTION: Most of the studies (except the birth cohorts) relied on retrospectively reported age at menarche, which may have led to some degree of recall bias. WIDER IMPLICATIONS OF THE FINDINGS: Our findings support early monitoring of women with early menarche, especially those who have no children, for preventive health interventions aimed at mitigating the risk of adverse health outcomes associated with early menopause. STUDY FUNDING/COMPETING INTEREST(S): InterLACE project is funded by the Australian National Health and Medical Research Council project grant (APP1027196). G.D.M. is supported by Australian Research Council Future Fellowship (FT120100812). There are no competing interests.
引用
- Mishra GD, Pandeya N, Dobson AJ, et al. Early menarche, nulliparity and the risk for premature and early natural menopause. Hum Reprod. 2017. PMID: 28119483. doi:10.1093/humrep/dew350
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。